EI

281.1

+0.25%↑

SAN

86.18

+1.07%↑

MRK1

119.3

-0.83%↓

SHL.DE

47.04

+1.1%↑

UCB

251

+1.29%↑

EI

281.1

+0.25%↑

SAN

86.18

+1.07%↑

MRK1

119.3

-0.83%↓

SHL.DE

47.04

+1.1%↑

UCB

251

+1.29%↑

EI

281.1

+0.25%↑

SAN

86.18

+1.07%↑

MRK1

119.3

-0.83%↓

SHL.DE

47.04

+1.1%↑

UCB

251

+1.29%↑

EI

281.1

+0.25%↑

SAN

86.18

+1.07%↑

MRK1

119.3

-0.83%↓

SHL.DE

47.04

+1.1%↑

UCB

251

+1.29%↑

EI

281.1

+0.25%↑

SAN

86.18

+1.07%↑

MRK1

119.3

-0.83%↓

SHL.DE

47.04

+1.1%↑

UCB

251

+1.29%↑

Search

Brenntag AG

Open

SectorHealthcare

53.22 0.68

Overview

Share price change

24h

Current

Min

52.36

Max

53.84

Key metrics

By Trading Economics

Income

-93M

43M

Sales

-203M

3.9B

P/E

Sector Avg

17.088

35.739

EPS

0.44

Dividend yield

4.13

Profit margin

1.116

Employees

17,502

EBITDA

-23M

317M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+13.58% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

4.13%

3.08%

Next Earnings

12 Nov 2025

Market Stats

By TradingEconomics

Market Cap

-705M

7.3B

Previous open

52.54

Previous close

53.22

News Sentiment

By Acuity

62%

38%

326 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Brenntag AG Chart

Past performance is not a reliable indicator of future results.

Related News

26 Jun 2025, 13:21 UTC

Market Talk

Volkswagen, BASF, DHL Owner Could Issue Profit Warnings -- Market Talk

16 Jun 2025, 10:04 UTC

Market Talk

Brenntag Expected to Have Volume, Margin Overhang -- Market Talk

Peer Comparison

Price change

Brenntag AG Forecast

Price Target

By TipRanks

13.58% upside

12 Months Forecast

Average 60.04 EUR  13.58%

High 85 EUR

Low 47 EUR

Based on 13 Wall Street analysts offering 12 month price targets forBrenntag AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

13 ratings

3

Buy

7

Hold

3

Sell

Technical Score

By Trading Central

57.48 / 59.9Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

326 / 371 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Brenntag AG

Brenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Germany, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates in two segments, Brenntag Essentials and Brenntag Specialties. It provides just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling. The company serves customers in various end-market industries, including nutrition, pharma, personal care, water treatment, and lubricants; and home, industrial, and institutional markets, as well as coatings and constructions, polymers, and rubber industries. The company was founded in 1874 and is based in Essen, Germany.
help-icon Live chat